bxp inc. - BXP

BXP

Close Chg Chg %
62.90 0.19 0.30%

Open Market

63.09

+0.19 (0.30%)

Volume: 91.95K

Last Updated:

Nov 13, 2026, 10:51 AM EDT

Company Overview: bxp inc. - BXP

BXP Key Data

Open

$63.31

Day Range

62.82 - 63.75

52 Week Range

49.72 - 74.94

Market Cap

$10.15B

Shares Outstanding

159.67M

Public Float

158.90M

Beta

1.05

Rev. Per Employee

N/A

P/E Ratio

19.03

EPS

$3.36

Yield

441.36%

Dividend

$0.70

EX-DIVIDEND DATE

Sep 30, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.51M

 

BXP Performance

1 Week
 
-3.26%
 
1 Month
 
6.23%
 
3 Months
 
-8.12%
 
1 Year
 
-10.97%
 
5 Years
 
-46.70%
 

BXP Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 72.474
Number of Ratings 22 Current Quarters Estimate 0.561
FY Report Date 12 / 2026 Current Year's Estimate 2.189
Last Quarter’s Earnings 0.71 Median PE on CY Estimate N/A
Year Ago Earnings 1.74 Next Fiscal Year Estimate 2.012
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 4 8 8
Mean Estimate 0.56 0.42 2.19 2.01
High Estimates 0.65 0.53 2.38 2.74
Low Estimate 0.47 0.34 1.90 1.52
Coefficient of Variance 10.69 20.21 8.88 21.15

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 9 9 10
OVERWEIGHT 2 2 2
HOLD 11 11 10
UNDERWEIGHT 0 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Bxp Inc. - BXP

Date Name Shares Transaction Value
Oct 1, 2026 William H. Walton Director 10,640 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 1, 2026 Bruce W. Duncan Director 14,660 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 1, 2026 Matthew J. Lustig Director 22,221 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 1, 2026 Julie G. Richardson Director 2,175 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 1, 2026 Mary E. Kipp Director 8,983 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 1, 2026 Joel Irwin Klein Director 25,088 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Oct 1, 2026 Derek Anthony West Director 5,235 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 3, 2026 Timothy J. Naughton Director 8,601 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 3, 2026 Diane J. Hoskins Director 18,929 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Hilary Spann Executive Vice President 23,327 Conversion of derivative security 0.00
Feb 27, 2026 Hilary Spann Executive Vice President of GP N/A Conversion of derivative security 0.00
Jan 28, 2026 Eric G. Kevorkian SVP, CLO and Secretary 511 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.11 per share 34,293.21
Jan 28, 2026 Michael E. LaBelle EVP and CFO 7,971 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.11 per share 534,933.81
Nov 26, 2025 Peter V. Otteni Executive Vice President N/A Open market or private sale of non-derivative or derivative security Non-derivative transaction at $72.65 per share 0.00
Nov 18, 2025 Peter V. Otteni Executive Vice President of GP N/A Conversion of derivative security 0.00
Nov 18, 2025 Peter V. Otteni Executive Vice President of GP 49,274 Conversion of derivative security 0.00

Bxp Inc. in the News